1.Surgical-orthodontic treatment for skeletal class III correction
Od B ; Otgontuya D ; Davaasuren A ; Bolormaa B ; Urtnasan A ; Purewsuren B ; Gantumur Ts
Mongolian Journal of Health Sciences 2025;87(3):103-107
Background:
Class III malocclusion is considered to be one of the most difficult
and complex orthodontic problems to treat. For patients whose orthodontic
problems are so severe that neither growth modification nor camouflage offers
solution, surgery to realign the jaws or reposition dentoalveolar segments is
the only possible treatment option left.
Aim:
The treatment objectives were to:
(1) level and align the dental arches; (2) obtain an ideal overbite and overjet,
to establish correct anterior guidance; and (3) improve the facial profile.
Case:
Patient is present with skeletal Class III malocclusion, concave facial profile,
facial proportion 0.96:1:1.04, loss of occlusion due to early molar teeth loss,
molar and canine relationship were Class III, overbite 0 mm, overjet -1 mm,
midline shifted into the 6 mm left side.
Results:
Excellent facial and occlusal
results were achieved with this surgical-orthodontic management, post-treatment
results showed a Class I relationship and ideal overjet and overbite. The
facial profile became straight type.
Conclusion
This case report describes
the treatment of a female with dental and skeletal class III relationships. Surgical-
orthodontic treatment was the best option for achieving an acceptable
occlusion and a good esthetic result in this case. An experienced multidisciplinary
team approach ensures a satisfactory outcome.
2.Association between serum ferritin levels and hepatic steatosis in patients with hepatitis c virus infection
Urtnasan Ts ; Oyunchimeg D ; Batbold B
Diagnosis 2025;113(2):74-80
Introduction:
According to the World Health Organization (WHO), by 2030, the number of deaths from cancer worldwide is estimated to reach 13.2 million. However, this number is expected to increase to 20.3 million due to population growth. As of 2018, liver cancer is the sixth most commonly diagnosed cancer and the fourth leading cause of cancer-related deaths worldwide. Hepatitis C virus (HCV) is one of the main causes of chronic liver disease, cirrhosis, and liver cancer.
HCV is estimated to infect 175 million people globally, accounting for 2.8–3% of the total population. About 20% of people infected with HCV progress to severe liver disease, sometimes requiring liver transplantation.
In our country, the prevalence of chronic hepatitis increased significantly between 2015 and 2019. In 2019, it accounted for 45.3% of the total liver diseases, an increase of 10.3 percentage points since 2015. When analyzing age groups, it is noteworthy that incidence increased by 3.2 times in children aged 0-9 years.
Objectives of the study:
To determine the level of ferritin in the blood of patients with hepatitis C virus infection and to assess its relationship with fatty liver.
Research materials and methods:
This study was conducted using a cross- sectional design. The data were collected before the initiation of anti-HCV treatment, and each participant underwent serum biochemical analysis to assess basic iron metabolism indicators such as ferritin and transferrin.
Conclusion
Of the 115 participants in the study, 27% (31) had elevated ferritin levels, while 73% (84) had normal levels. The mean ferritin level was 336±262 ng/ mL, indicating that a significant number of participants had elevated ferritin levels. This suggests that ferritin levels are increased in cases of liver cell inflammation and injury. Although biopsy-proven fatty liver disease was not present, 97.4% (112) of the participants had elevated blood lipid levels, and 94.6% of these had elevated ferritin levels. However, the chi-square test did not reveal a statistically significant difference (χ² = 0.170, p = 0.681). Additionally, 91.5% of participants with high HDL also had elevated ferritin, but the relationship was not statistically significant (p = 0.117).
3.Morbidity and mortality trend of respiratory diseases in children aged 0-4 years in Ulaanbaatar
Mongolian Medical Sciences 2020;193(3):59-67
Rationale:
The most common reasons of childhood deaths is Respiratory Tract Infections and every year, 3
million out of 5 million children under five years of age suffering from respiratory diseases die due to
lung inflammation (Stansfield et al, 1993).
In Ulaanbaatar live 182016 children aged 0-4 years and it around 45 percent of the total population
in 2018. Ulaanbaatar is ranked first place in the world by air pollution, especially, atmospheric
particulate matter (PM2.5) are much higher than the average annual concentrations indication in
the recommendations of World Health Organization. This brings high risk of respiratory diseases
morbidity and mortality to the children.
It is need to study the last ten-year trend of respiratory diseases which to happen to the children
under five years of age, and it should be reduced the respiratory illness of young children.
Objective:
To study the last ten-year morbidity and mortality trend of respiratory diseases among children aged
0-4 in Ulaanbaatar.
Methodology:
We have been investigated the trend-survey of the respiratory disease morbidity and mortality of
children aged 0-4 in Ulaanbaatar based on the last ten-year statistical data of the Ulaanbaatar Health
Department. The population was estimated at 10000 people.
Result:
Hospital admissions because of respiratory diseases of children under 5-year-old were 3629,9-2009;
3827,3-2010; 3890-2011; 3958,3-2012; 4825,7-2013; 5723,5-2014 4669,4-2015; 5839,3-2016;
5624,4-2017; 4754.9-2018; 3811-2019 respectively, per 10000 people in Ulaanbaatar. The number
of hospitalized patients due to respiratory diseases of Ulaanbaatar is increasing gradually from 2009
to 2019.
Respiratory disease mortality was 20,8 in 2008; 21-2009; 20,6-2010; 16,2-2011; 16-2012; 16,4-2013;
17,8-2014; 17,3-2015; 18,2-2016; 15,4-2017; 16.1-2018; 14.1-2019 respectively and mortality rate
has been slightly decreased in recent years.
Conclusion
Although respiratory illness of children aged 0-4 in Ulaanbaatar has been steadily increasing over
the past decade, the children mortality has been decreasing in recent years, gradually. Furthermore,
it shall be studied of air quality and outdoor indoor air pollution-related diseases among children,
detailed.
4.Risk factors influencing on respiratory disease morbidity and mortality of children under 5 years old
Mongolian Medical Sciences 2019;190(4):60-66
Respiratory diseases morbidity and mortality rate of children between 0-5 age is considerably high
in the US, China and East Asian countries. Studies conducted in Mongolia reveals that respiratory
diseases morbidity rate of children between 1-4 age is very high in UB. Respiratory diseases case of
children aged between 0-5 is predominantly registered in UB. Recent trend suggests that respiratory
disease case of children aged between 0-5 shows no sign of decreasing, instead it is increasing. In
addition to virus and bacteria, social factors have been one of the main influencers to respiratory
diseases morbidity among small children, it was concluded.
Result Analysis
Print
Save
E-mail